After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Neogenomics Inc. (NEO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.28, or 1.83%, to $15.55. The Neogenomics Inc. has recorded 28,646 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios.
NEO belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $15.27 and fluctuated between $15.47 as its day high and $14.71 as its day low. The current market capitalization of Neogenomics Inc. is $1.95B. A total of 0.99 million shares were traded on the day, compared to an average of 901.36K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, NEO has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 1,680 shares. Over the last 12 months, there were 6 BUYs and 9 SELLs from insiders. Insiders purchased 332,972 shares during that period but sold 29,477.
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. NEO’s most recent ex-dividend date was 12/17/2020 when it declared a $0.40 quarterly dividend that was paid in cash on 12/30/2020.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for NEO in the last 3 months, the mean price target is $20.18 with high estimates of $26.00 and low estimates of $15.00. In terms of 52-week highs and lows, NEO has a high of $20.54 and a low of $6.97.
As of this writing, NEO has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of -$0.05 per share and a lower estimate of -$0.16. The company reported an EPS of -$0.09 in the last quarter, which was 40.00% higher than expectations of -$0.15.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NEO’s latest balance sheet shows that the firm has $515.39M in Cash & Short Term Investments as of fiscal 2021. There were $612.79M in debt and $87.23M in liabilities at the time. Its Book Value Per Share was $7.52, while its Total Shareholder’s Equity was $1.11B.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NEO is Buy with a score of 4.42.